Most Cited Articles

Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease

, 2013; 10(1): 104-107

MA Nunes, TA Viel, SH Buck

DOI: 10.2174/1567205011310010014

Pathogenesis of Abeta Oligomers in synaptic failure

, 2013; 10(3): 316-323

S Sivanesan, A Tan, J Rajadas

DOI: 10.2174/1567205011310030011

Immunotherapy for targeting tau pathology in Alzheimer's disease and tauopathies

, 2013; 10(3): 217-228

H Rosenmann

DOI: 10.2174/1567205011310030001

The safety, tolerability, pharmacokinetics and cognitive effects of GSK239512, a selective histamine H3 receptor antagonist in patients with mild to moderate Alzheimer's disease: A preliminary investigation

, 2013; 10(3): 240-251

PJ Nathan, R Boardley, N Scott, A Berges, P Maruff, T Sivananthan, N Upton, MT Lowy, PJ Nestor, R Lai

DOI: 10.2174/1567205011310030003

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

, 2012; 9(1): 35-66

SM de la Monte

DOI: 10.2174/156720512799015037

Overview and findings from the rush memory and aging project

, 2012; 9(6): 646-663

DA Bennett, JA Schneider, AS Buchman, LL Barnes, PA Boyle, RS Wilson

DOI: 10.2174/156720512801322663

University of kentucky sanders-brown healthy brain aging volunteers: Donor characteristics, procedures and neuropathology

, 2012; 9(6): 724-733

FA Schmitt, PT Nelson, E Abner, S Scheff, GA Jicha, C Smith, G Cooper, M Mendiondo, DD Danner, LJ van Eldik, A Caban-Holt, MA Lovell, RJ Kryscio

DOI: 10.2174/156720512801322591

N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease

, 2012; 9(6): 746-758

D Olivares, VK Deshpande, Y Shi, DK Lahiri, NH Greig, JT Rogers, X Huang

DOI: 10.2174/156720512801322564

Overview and findings from the religious orders study

, 2012; 9(6): 628-645

DA Bennett, JA Schneider, Z Arvanitakis, RS Wilson

DOI: 10.2174/156720512801322573

Webmaster Contact:
Copyright © 2018 Bentham Science